Pulmonary Hypertension Archives - Page 2 of 37

Because oxidative stress and elevated ASK1 activity appear to play a role in vascular remodeling in PAH, ASK1 inhibition with selonsertib was studied.

pulmonary arterial hypertension xray front view

CHEST 2021

Inhaled Treprostinil and Lung Function in Patients With PH-ILD and PAH

By

Virginia A. Schad, PharmD, RPh

October 15, 2021

A post-hoc analysis compared lung function changes in the INCREASE and TRIUMPH trials of inhaled treprostinil for PH-ILD and PAH.

Pulmonary Hypertension

Initial Triple vs Dual Oral Combination Therapy for Newly Diagnosed PAH

By

Jessica Nye, PhD

October 8, 2021

A study investigated the efficacy of double or triple pharmacotherapy in pulmonary arterial hypertension.

Critical Care

Outcomes for Milrinone vs Dobutamine in Cardiogenic Shock

By

Brandon May

September 13, 2021

Which inotropic agent should clinicians use in patients with cardiogenic shock, milirone or dobutamine?

Pulmonary Hypertension

Presence of Pleural vs Pericardial Effusion in Patients With Pulmonary Hypertension

By

Sheila Jacobs

September 9, 2021

Researchers examined the link between pulmonary hemodynamic variables and the presence of pericardial and pleural effusion.

Pulmonary Hypertension

Precapillary Pulmonary Hypertension: Patient Characteristics and Prognosis

By

Bryant Moeller

September 2, 2021

Is the 2018 World Symposium on Pulmonary Hypertension definition of pre-capillary pulmonary hypertension beneficial in clinical practice?

Pulmonary Hypertension

Inhaled Imatinib Designated Orphan Drug for Pulmonary Arterial Hypertension

By

Brian Park, PharmD

August 31, 2021

AER-901 is an investigational drug-device combination therapy that consists of a nebulized formulation of imatinib and the Fox device, a breath-actuated smart nebulizer.